Scarica l'app Stockscreener
35.70
0.51%
0.18
Pre-mercato:
35.50
-0.20
-0.56%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$35.52
Aprire:
$35.45
Volume 24 ore:
419.32K
Relative Volume:
0.98
Capitalizzazione di mercato:
$1.07B
Reddito:
$1.37B
Utile/perdita netta:
$54.85M
Rapporto P/E:
20.14
EPS:
1.7729
Flusso di cassa netto:
$123.71M
1 W Prestazione:
-4.11%
1M Prestazione:
-0.72%
6M Prestazione:
-17.78%
1 anno Prestazione:
-38.12%
Intervallo 1D:
$35.21
$36.01
Intervallo di 1 settimana:
$34.52
$37.31
Portata 52W:
$33.21
$60.35
Conmed Corp Stock (CNMD) Company Profile
Nome
Conmed Corp
Settore
Industria
Telefono
727-214-2974
Indirizzo
11311 CONCEPT BOULEVARD, LARGO, NY
Compare CNMD vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
35.70 | 1.07B | 1.37B | 54.85M | 123.71M | 1.7729 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-17 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-06-12 | Downgrade | Needham | Buy → Hold |
| 2025-04-28 | Downgrade | Stifel | Buy → Hold |
| 2025-02-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-02-01 | Reiterato | Needham | Buy |
| 2023-05-22 | Iniziato | CL King | Buy |
| 2023-03-27 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-03-21 | Iniziato | Wells Fargo | Equal Weight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2021-10-06 | Aggiornamento | Needham | Hold → Buy |
| 2021-07-15 | Iniziato | UBS | Buy |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2019-11-26 | Downgrade | Needham | Buy → Hold |
| 2019-11-12 | Iniziato | JP Morgan | Overweight |
| 2019-10-31 | Reiterato | Needham | Buy |
| 2019-10-04 | Reiterato | Needham | Buy |
| 2019-08-22 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2019-04-18 | Iniziato | Stifel | Buy |
| 2019-04-16 | Reiterato | Needham | Buy |
| 2019-01-23 | Reiterato | Needham | Buy |
| 2018-10-16 | Iniziato | Barclays | Equal Weight |
| 2018-08-07 | Reiterato | Needham | Buy |
| 2018-08-02 | Reiterato | Needham | Buy |
| 2018-04-26 | Reiterato | Needham | Buy |
| 2018-02-01 | Reiterato | Needham | Buy |
| 2017-07-27 | Reiterato | Needham | Buy |
| 2017-04-27 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2017-04-27 | Reiterato | Needham | Buy |
| 2016-11-18 | Reiterato | Needham | Buy |
| 2016-07-28 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| 2016-04-28 | Reiterato | Needham | Buy |
| 2015-10-22 | Reiterato | Northland Capital | Market Perform |
Mostra tutto
Conmed Corp Borsa (CNMD) Ultime notizie
Clip Applicator Market Will Generate Booming Growth - openPR.com
(CNMD) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
CONMED Corp stock (US2074101013): focus on growth after latest quarterly results - AD HOC NEWS
CONMED Corporation Announces Results of 2026 Annual Meeting, Amended By-Laws, and Director Compensation Updates - Minichart
Conmed appoints two directors to board effective July 1 - Investing.com
Celine Martin and Jeff Mirviss join ConMed board; Kimberly Lockwood named interim controller - TradingView
New CONMED (NYSE: CNMD) directors, bylaw changes and 2026 vote outcomes - Stock Titan
J&J and Boston Scientific veterans join CONMED's board - Stock Titan
CONMED Corp stock (US2074101013): shares react to Q1 2026 results and updated full-year outlook - AD HOC NEWS
Is the Options Market Predicting a Spike in CONMED Stock? - Yahoo Finance UK
Oppenheimer Asset Management Inc. Has $1.27 Million Stock Holdings in CONMED Corporation $CNMD - MarketBeat
Does CONMED (CNMD) Refocusing Away From Gastroenterology Clarify Its Long-Term Surgical Growth Story? - Yahoo Finance
Assessing CONMED (CNMD) Valuation After A Mixed Stretch In Recent Share Performance - Yahoo Finance
Is CONMED Corporation (CNMD) A Good Stock To Buy Now? - Yahoo Finance
CNMD Q1 Deep Dive: GI Exit Refocuses Growth on Core Surgical Platforms - Yahoo Finance
CONMED (NYSE:CNMD) Stock Rating Lowered by Wall Street Zen - MarketBeat
Healthcare Momentum Story Meets NYSE Composite Trends - Kalkine Media
CONMED (NYSE:CNMD) Price Target Lowered to $39.00 at Wells Fargo & Company - MarketBeat
CNMD SEC FilingsConmed Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Conmed (CNMD) Q1 2026 Earnings Transcript - AOL.com
CONMED (NYSE:CNMD) Price Target Lowered to $40.00 at JPMorgan Chase & Co. - MarketBeat
CONMED Corp 1Q 2026: Revenue $317M, EPS $0.45— 10-Q Summary - TradingView
CONMED (NYSE: CNMD) boosts Q1 2026 profit as margins expand - Stock Titan
CONMED Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
CONMED's Q1 Earnings and Revenues Beat, Organic Sales Outlook Up - Yahoo Finance
Conmed Corp (CNMD) Q1 2026 Earnings Call Highlights: Navigating Challenges and Capitalizing on ... By GuruFocus - Investing.com Canada
CONMED Q1 Earnings Call Highlights - MarketBeat
CONMED (NYSE:CNMD) Releases Earnings Results, Beats Estimates By $0.07 EPS - MarketBeat
CONMED Corporation (NYSE:CNMD) Beats Q1 Estimates and Raises Revenue Guidance, Shares Steady - ChartMill
Compared to Estimates, Conmed (CNMD) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
CONMED ($CNMD) Releases Q1 2026 Earnings - Quiver Quantitative
Conmed (CNMD) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
CONMED Q1 2026 slides: organic growth rises as GI exit weighs - Investing.com
Earnings call transcript: CONMED beats Q1 2026 forecasts, stock dips - Investing.com
Vanguard reports 1.62M shares in CONMED (NASDAQ: CNMD) as of 03/31/2026 - Stock Titan
CONMED’s (NYSE:CNMD) Q1 CY2026 Sales Beat Estimates - Barchart.com
Conmed: Q1 Earnings Snapshot - marketscreener.com
Q1 2026: CONMED (NYSE: CNMD) lifts 2026 sales outlook, EPS $0.45 - Stock Titan
Medical device maker CONMED cut sales but raised its 2026 forecast - Stock Titan
CONMED Corporation Announces First Quarter 2026 Financial Results - Yahoo Finance
Vanguard Portfolio Management (CNMD) reports 2.12M shares; 6.87% stake - Stock Titan
CONMED earnings on deck: Can AirSeal stabilize amid pressure? By Investing.com - Investing.com Canada
CONMED earnings on deck: Can AirSeal stabilize amid pressure? - Investing.com
Here's why you should retain CONMED stock in your portfolio now - MSN
CONMED Earnings: What To Look For From CNMD - Yahoo Finance
Conmed Corp Azioni (CNMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.59%
1.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):